Public dataset
Recorded source agreement and disagreement
Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.
- Public rows
- 1,681
- Generated
- Schema version
- source-consensus/2
Coverage
What this run contains
- Compared medicine fields
- 1,681
- Agree
- 1,282
- Differ
- 0
- Not comparable
- 12
- Insufficient context
- 387
- Fields represented
- 5
- bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
Method
How the rows were made
- Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
- One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
- Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
- not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
- The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
- Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
- documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.
Limits
Read these before using a row
- Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
- The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
- Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
- Only the recorded fields and source documents in this snapshot are compared.
- A source count is the number of retained source records in the row, not a count of independent experiments.
Provenance
Source examples
abacavir · bioavailability · agree
15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)The geometric mean absolute bioavailability of the tablet was 83%.
alemtuzumab · volumeOfDistribution · not_comparable
2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).
abiraterone · halfLife · insufficient_context
31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)
FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.
Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.
Schema
Fields in the public projection
| Field | Type | Meaning |
|---|---|---|
| medicineSlug | string | Stable RNAWiki medicine route key. |
| field | string | Recorded pharmacokinetic field being compared. |
| comparisonState | string | agree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero. |
| comparisonReasons | string[] | Deterministic codes explaining the state. |
| documentsExamined | number | Recorded source documents considered for the field. |
| sourceCount | number | Recorded source readings represented. |
| agreementRate | number | Share represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability. |
| readings | consensus-reading[] | Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt. |
Reader
Search and filter the rows
Showing 311–320 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.
Projected row 311
- Medicine slug
- cladribine
- Compared field
- volumeOfDistribution
- Comparison state
- not_comparable
- Reason codes
- DENOMINATOR_MISMATCH
- Documents examined
- 8
- Source count
- 8
- Agreement rate
- 0.5
- Recorded readings
4.5±2.8 L/kg
- Numeric value
- 4.5
- Unit
- L/kg
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71c39b37-33b5-42e1-bf4f-93ff751cc7fe (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Mean values for clearance and steady-state volume of distribution were 978±422 mL/h/kg and 4.5±2.8 L/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2592a9b-bca6-4a5a-89c2-855a0634d5fe (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Mean values for clearance and steady-state volume of distribution were 978 ± 422 mL/h/kg and 4.5 ± 2.8 L/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f538cba9-001a-4a21-e053-2a95a90a00ec (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Mean values for clearance and steady-state volume of distribution were 978±422 mL/h/kg and 4.5±2.8 L/kg, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5736aecc-cc1d-47dd-86c0-5fb2e9d70f61 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Mean values for clearance and steady-state volume of distribution were 978 ± 422 mL/h/kg and 4.5 ± 2.8 L/kg, respectively.
480 to 490 liters
- Numeric value
- 480
- Unit
- L
- Source records
- 4
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 4 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f1d650a5-4205-720b-f39b-4213277b6612 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Distribution Cladribine mean apparent volume of distribution ranges from 480 to 490 liters.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e0b363cb-db83-44d6-89d0-1f7176be7459 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Distribution Cladribine mean apparent volume of distribution ranges from 480 to 490 liters.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9c75e30a-a410-40f1-b653-04d532bd9144 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Distribution Cladribine mean apparent volume of distribution ranges from 480 to 490 liters.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:407c52d5-6498-7da5-da35-acc9ca73ced3 (opens source in a new tab)
Cladribine label
Version not recorded · Effective date not recorded
Distribution Cladribine mean apparent volume of distribution ranges from 480 to 490 liters.
Projected row 312
- Medicine slug
- clarithromycin
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 42
- Source count
- 35
- Agreement rate
- 1
- Recorded readings
50%
- Numeric value
- 50
- Unit
- %
- Source records
- 35
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 35 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa69ea92-0b41-43fb-918f-ed80e0dedf04 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a12e4d38-e0f8-4467-a26c-bb25a342aa92 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bf207c0-86eb-4f3b-92e7-f65f3fccd5a7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b98b02bb-2609-49a0-b29f-e5911aa0cbc1 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d836ae7e-fdbf-4dcb-a90d-ede1dcbc3e67 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9aaffb41-408c-4372-8fd5-1d649450c0e9 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d6cfd87-9b8c-bba9-e063-6294a90aff5a (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7d8391-50ef-4827-abe6-e0fc0c2f1636 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471f638a-9dd1-09d3-e063-6294a90a2d4f (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:268d21f9-02c9-41b0-9487-7968ea12720d (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Immediate-Release Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9143b79c-4c79-43ac-e053-2995a90ad708 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d6f5a9d-51b2-4e0d-b573-ccf08fe6ea23 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:81c0c69e-b1ae-42f3-9e85-09b8daa75d8d (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88c7ded8-333c-408d-b693-a72881710f59 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c4db97f-f4c9-4cac-9f12-9db1d967ebeb (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba216276-b0bd-420a-9e0d-090bdfcc2460 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98aacb4-2f01-3e94-e053-6294a90a9aa0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0be243c6-de02-45dd-8210-cab1bbc8dfa7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d5848f0-e9f0-4112-a7ca-bcc8ea2e69c6 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59ebe6cb-c830-45c7-8242-52f9f42a90a0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27e02b77-4332-49e0-8d0c-a072cf5dff92 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cb8a78a-0f07-49e8-a23e-a77628006209 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9eb306e0-ccfb-418c-82ca-204f20a788f7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a66646-6774-4fc6-9b26-a98c3a5df274 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de33ba3a-9df1-4076-8d5f-b603d2698096 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Immediate-Release Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1920f943-bbf1-cfd9-7475-96a35680a9e0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cde51c9f-f7b8-413f-8b8e-e56370cd5754 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Immediate-Release Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adba78c2-9e51-4bed-8c6a-6f977f79c40c (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d22bd12c-737b-4aab-e053-2995a90aff60 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.1 Mechanism of Action Clarithromycin is a macrolide antimicrobial drug [see Microbiology (12.4)]. 12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25debd85-0840-4f8d-9898-027772061dd2 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ba1da51-ba5b-323f-e063-6294a90a0333 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.1 Mechanism of Action Clarithromycin is a macrolide antimicrobial drug [see Microbiology (12.4)]. 12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99d2fd6b-39ca-42f9-ad06-30e7fbc22c47 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Immediate-Release Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28f60574-4ecd-441c-aebe-5b1d18033ef6 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption Clarithromycin Tablets The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1bdf526-4f16-4130-b614-4cb678f060d7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d42821d-ce7a-7d64-e063-6294a90a0875 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
12.3 Pharmacokinetics Absorption The absolute bioavailability of 250 mg clarithromycin tablets was approximately 50%.
Projected row 313
- Medicine slug
- clarithromycin
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 42
- Source count
- 40
- Agreement rate
- 0.95
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 38
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 38 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa69ea92-0b41-43fb-918f-ed80e0dedf04 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a12e4d38-e0f8-4467-a26c-bb25a342aa92 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bf207c0-86eb-4f3b-92e7-f65f3fccd5a7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b98b02bb-2609-49a0-b29f-e5911aa0cbc1 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d836ae7e-fdbf-4dcb-a90d-ede1dcbc3e67 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:71a836d0-d60f-6418-e053-2a95a90aa6ef (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
Elimination half-life of clarithromycin (3 hours to 4 hours) and that of 14-OH clarithromycin (5 hours to 7 hours) were similar to those observed at steady state following administration of equivalent doses of clarithromycin immediate-release tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9aaffb41-408c-4372-8fd5-1d649450c0e9 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d6cfd87-9b8c-bba9-e063-6294a90aff5a (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7d8391-50ef-4827-abe6-e0fc0c2f1636 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471f638a-9dd1-09d3-e063-6294a90a2d4f (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:268d21f9-02c9-41b0-9487-7968ea12720d (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9143b79c-4c79-43ac-e053-2995a90ad708 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d6f5a9d-51b2-4e0d-b573-ccf08fe6ea23 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:81c0c69e-b1ae-42f3-9e85-09b8daa75d8d (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88c7ded8-333c-408d-b693-a72881710f59 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c4db97f-f4c9-4cac-9f12-9db1d967ebeb (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba216276-b0bd-420a-9e0d-090bdfcc2460 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98aacb4-2f01-3e94-e053-6294a90a9aa0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0be243c6-de02-45dd-8210-cab1bbc8dfa7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d5848f0-e9f0-4112-a7ca-bcc8ea2e69c6 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59ebe6cb-c830-45c7-8242-52f9f42a90a0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d5be5f12-6392-4d7d-ab23-ebc205ac1a85 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
Elimination half-life of clarithromycin (3 hours to 4 hours) and that of 14-OH clarithromycin (5 hours to 7 hours) were similar to those observed at steady state following administration of equivalent doses of clarithromycin immediate-release tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27e02b77-4332-49e0-8d0c-a072cf5dff92 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cb8a78a-0f07-49e8-a23e-a77628006209 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d328f5d-73c1-4df7-a3df-71d0e0221181 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
Elimination half-life of clarithromycin (3 hours to 4 hours) and that of 14-OH clarithromycin (5 hours to 7 hours) were similar to those observed at steady state following administration of equivalent doses of clarithromycin immediate-release tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a66646-6774-4fc6-9b26-a98c3a5df274 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de33ba3a-9df1-4076-8d5f-b603d2698096 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1920f943-bbf1-cfd9-7475-96a35680a9e0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cde51c9f-f7b8-413f-8b8e-e56370cd5754 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adba78c2-9e51-4bed-8c6a-6f977f79c40c (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d22bd12c-737b-4aab-e053-2995a90aff60 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25debd85-0840-4f8d-9898-027772061dd2 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ba1da51-ba5b-323f-e063-6294a90a0333 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d4303f8-88dd-8b88-e063-6394a90ab48f (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
Elimination half-life of clarithromycin (3 hours to 4 hours) and that of 14-OH clarithromycin (5 hours to 7 hours) were similar to those observed at steady state following administration of equivalent doses of clarithromycin immediate-release tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99d2fd6b-39ca-42f9-ad06-30e7fbc22c47 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28f60574-4ecd-441c-aebe-5b1d18033ef6 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dea5bd78-7f93-4bc4-a2e4-1b021f5fe098 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
Elimination half-life of clarithromycin (3 hours to 4 hours) and that of 14-OH clarithromycin (5 hours to 7 hours) were similar to those observed at steady state following administration of equivalent doses of clarithromycin immediate-release tablets.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d42821d-ce7a-7d64-e063-6294a90a0875 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 hours to 4 hours with 250 mg administered every 12 hours but increased to 5 hours to 7 hours with 500 mg administered every 8 hours to 12 hours.
3 to 4 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 2
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 2 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9eb306e0-ccfb-418c-82ca-204f20a788f7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 to 4 hours with 250 mg administered every 12 hours but increased to 5 to 7 hours with 500 mg administered every 8 to 12 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1bdf526-4f16-4130-b614-4cb678f060d7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
The elimination half-life of clarithromycin was about 3 to 4 hours with 250 mg administered every 12 hours but increased to 5 to 7 hours with 500 mg administered every 8 to 12 hours.
Projected row 314
- Medicine slug
- clarithromycin
- Compared field
- tMax
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 42
- Source count
- 35
- Agreement rate
- 1
- Recorded readings
2 to 3 hours
- Numeric value
- 2
- Unit
- hours
- Source records
- 35
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 35 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa69ea92-0b41-43fb-918f-ed80e0dedf04 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a12e4d38-e0f8-4467-a26c-bb25a342aa92 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9bf207c0-86eb-4f3b-92e7-f65f3fccd5a7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b98b02bb-2609-49a0-b29f-e5911aa0cbc1 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d836ae7e-fdbf-4dcb-a90d-ede1dcbc3e67 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9aaffb41-408c-4372-8fd5-1d649450c0e9 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2d6cfd87-9b8c-bba9-e063-6294a90aff5a (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c7d8391-50ef-4827-abe6-e0fc0c2f1636 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:471f638a-9dd1-09d3-e063-6294a90a2d4f (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:268d21f9-02c9-41b0-9487-7968ea12720d (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9143b79c-4c79-43ac-e053-2995a90ad708 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d6f5a9d-51b2-4e0d-b573-ccf08fe6ea23 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:81c0c69e-b1ae-42f3-9e85-09b8daa75d8d (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:88c7ded8-333c-408d-b693-a72881710f59 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0c4db97f-f4c9-4cac-9f12-9db1d967ebeb (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba216276-b0bd-420a-9e0d-090bdfcc2460 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f98aacb4-2f01-3e94-e053-6294a90a9aa0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0be243c6-de02-45dd-8210-cab1bbc8dfa7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9d5848f0-e9f0-4112-a7ca-bcc8ea2e69c6 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:59ebe6cb-c830-45c7-8242-52f9f42a90a0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:27e02b77-4332-49e0-8d0c-a072cf5dff92 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1cb8a78a-0f07-49e8-a23e-a77628006209 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9eb306e0-ccfb-418c-82ca-204f20a788f7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In nonfasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d0a66646-6774-4fc6-9b26-a98c3a5df274 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de33ba3a-9df1-4076-8d5f-b603d2698096 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1920f943-bbf1-cfd9-7475-96a35680a9e0 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cde51c9f-f7b8-413f-8b8e-e56370cd5754 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adba78c2-9e51-4bed-8c6a-6f977f79c40c (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d22bd12c-737b-4aab-e053-2995a90aff60 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing. clarithrofigure2 Figure 2: Steady-State Clarithromycin Plasma Concentration-Time Profiles Distribution Clarithromycin and the 14-OH clarithromycin metabolite distribute readily into body tissues and fluids.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:25debd85-0840-4f8d-9898-027772061dd2 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3ba1da51-ba5b-323f-e063-6294a90a0333 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:99d2fd6b-39ca-42f9-ad06-30e7fbc22c47 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:28f60574-4ecd-441c-aebe-5b1d18033ef6 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b1bdf526-4f16-4130-b614-4cb678f060d7 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In nonfasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4d42821d-ce7a-7d64-e063-6294a90a0875 (opens source in a new tab)
Clarithromycin label
Version not recorded · Effective date not recorded
In non-fasting healthy human subjects (males and females), peak plasma concentrations were attained within 2 to 3 hours after oral dosing.
Projected row 315
- Medicine slug
- clindamycin
- Compared field
- halfLife
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 158
- Source count
- 102
- Agreement rate
- 0.784314
- Recorded readings
2.4 hours
- Numeric value
- 2.4
- Unit
- hours
- Source records
- 80
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 80 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd2ca915-5672-440d-a14e-b4d3b6a522f3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2b13d66d-4f48-477e-ba32-20e85d0e708d (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:22bf9385-cad3-43a7-802f-131b6826b5a5 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d760cb7-d166-6707-e063-6394a90a8850 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7537fbab-c792-4b77-8736-c24b69cf48ea (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e8167412-882e-4143-93c6-49e68adbcf16 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7b110bab-815e-4654-860b-b9142fd93d45 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4730ab20-09e2-d32a-e063-6394a90ae125 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d53a66bf-fdbd-4a12-8d8c-4e3ab94e9ef5 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e68cb17-73d9-8a00-e053-2995a90a517f (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8af1493c-1f22-4629-a432-f8b0578189e1 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f2f08e98-f6c5-7c2d-e053-2995a90abe1e (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4f0ddf1a-eda6-8ca8-e063-6294a90a4102 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9e6ed50-ad03-4a9e-8760-8733e04a058c (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b22be885-f441-473e-879a-862588dcf89d (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de7001d1-8b83-4f8b-8e50-c07691021456 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fadc321a-2291-4268-936f-0743fdddbe7f (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:337870c6-11e0-4d1a-a26e-afe042ee08c3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:63f26644-b7ab-98c1-e053-2a91aa0af5d3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07f5d841-9c58-4dd1-b0bc-e12553931c8e (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bea7de4c-c077-4535-96a0-f6b319120b0b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2178249b-a9fe-5015-e063-6294a90a9ff4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2de041be-1d36-ee95-e063-6294a90a2091 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9fe68a5a-487b-4119-9ee7-603948d732e4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:adf8f0fa-f794-4e97-a7b3-16b55d9c9a68 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:df9a2a41-b132-4f43-8940-b2d773b1369a (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:afeb96ed-7c2e-72d3-e053-2995a90a4ed3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7f7fc73a-86e1-4d3e-8c83-1c74621e4af4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18ef4551-4066-4765-90cb-285d7711cf61 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b43dc396-17ef-a523-e053-2a95a90ac872 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:09eea0ad-702f-4eea-bfb9-81effc76b22b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:87db8bce-1b6f-4f1b-ab62-b3778c429b2e (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a69260bb-31b5-4f77-e053-2995a90a37e1 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1d562ae9-5a9a-4fed-8cc7-3f30fb40f957 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cd5a1db8-9ddf-4de3-b856-bc3e8fb29061 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2393251d-33b9-4274-9d04-27ec9968eaa1 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dd9e6b0-bcf4-5bf4-e063-6394a90a10c2 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c6703df0-b41d-439f-8e0d-d30b3039b3f8 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f6f5c8b2-83a1-5362-e053-6394a90aaaad (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2a810f1-c009-e973-e053-2a95a90ad5b0 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b2bd8402-c887-5bfd-e053-2a95a90a15d9 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:11e8dd9c-81fd-4e88-e063-6294a90af13e (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2290109b-45c9-1aab-e063-6294a90a673b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c3f35f80-e4ae-95f5-e053-2995a90a1b64 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:427a0138-c2dd-cf0b-e063-6394a90af407 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ba9bd5cd-036b-4b0c-e053-2a95a90a332e (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2367340c-d297-4a3f-8253-6d27a0ed39cb (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a2f6fa76-a114-4104-e053-2a95a90a9e0b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d1aa1e91-4ac8-40d1-9fc4-963e1c9c3278 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:47f76d99-2024-4531-a527-66c80deeeb37 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1dbd8448-c1e5-46df-8060-50ef82380445 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:24595bb3-07ea-4d5f-9bb3-2c2332a1fc62 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:bde81d4b-ad21-cc09-e053-2995a90a8c01 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:158e6c0c-1ca3-49a6-84fd-54d8fde7c2a7 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3256c93b-f26c-aeb9-e063-6394a90ae9c2 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e4d91d51-b92e-4d3e-8379-f9463f450537 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e66de7a-d9d4-4562-bc99-80489d482da4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e08eea9e-464c-429e-9584-b768f5127767 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f7e51a42-bc9e-490f-b8d8-8765f0b5be46 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9fe44bdd-eb59-4b55-e053-2995a90a3183 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12dea490-e179-f295-e063-6394a90af4aa (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f4c4fce0-0472-45a3-b4c6-192d97ca1818 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:678912ff-a0c1-171b-e053-2991aa0ad128 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a0fbeae-2bc2-2402-e063-6394a90a97a0 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3bddb5d2-ddac-2f03-e063-6294a90aa68c (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:ebdcd3ce-3140-4bf6-b8b8-468ead08d9a9 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:51dfa3fa-6f6a-4904-a8d3-b5938cf9c852 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9b9f898f-6a91-44f8-9508-f9ddfaad27bc (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1f1b9230-b8ef-b0e4-e063-6394a90afc47 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5f6a85c5-dca3-49b1-a029-3818a41d49bf (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f781897a-ab54-7373-e053-6294a90a89a3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:600c5ac7-64f7-44ac-9e83-cc1036471eec (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d6e1a5f2-9dcb-49fb-a5b0-d7d543520ac3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c46cac0a-0c36-02fa-e053-2995a90a772b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fa084aad-07fa-44d2-8d01-d32f40acd2f3 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3f6b2c5a-e581-414f-bc9e-eaf66a5685cd (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:509a9bc3-0901-0874-e063-6294a90a8816 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7d3e6ec5-93e9-4ce0-8276-b19aa97eb772 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:535e7e17-d020-4aa6-e063-6294a90ae114 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8e3c9cf6-ab39-4fb5-94e3-232880c47700 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion The average biological half-life is 2.4 hours.
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 18
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 18 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc8b8a09-3eed-1998-e053-2995a90a2f60 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a6967b3-5563-4bed-9eee-d400f800e799 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e4fc2d5-985a-3734-e053-2995a90aef5b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12ee0720-9979-3162-e063-6394a90a8003 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e545c9d-dc39-584c-e053-2995a90afda4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a42c3b2-90b5-4a78-9f18-fa789742b033 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e549ceb-00e8-64b8-e053-2a95a90aef0f (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:406534a6-2234-4735-ba8f-7de4c87592e6 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a4e2ba4-90e6-48e8-a943-0c5d3f169780 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:184acaee-6129-479e-850f-d89575b8b391 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44fa506b-90ac-42de-831b-5f3f1a500fc0 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2.5 hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05a75685-0af5-407c-ac57-e380c882b49d (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38416189-844b-939f-e063-6394a90aa271 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78832ac6-04c5-45e0-ae4d-f56d7920dda9 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:896a046f-95d0-100e-e053-2a95a90aa59c (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e500a08-0339-eb6b-e053-2a95a90a130c (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e5365a0-dd47-264a-e053-2a95a90a7fb8 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
Excretion Biologically inactive clindamycin phosphate disappears from the serum with 6 minutes of the average elimination half-life; however, the average serum elimination half-life of active clindamycin is about 3 hours in adults and 2½ hours in pediatric patients.
1.5 to 2.6 hours
- Numeric value
- 1.5
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b52bdaf7-3b54-4165-9ab0-9dfa08170e47 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
The systemic half-life was 1.5 to 2.6 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9be442d-0782-4b93-828f-9ebbf67dbced (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
The systemic half-life was 1.5 to 2.6 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:997a23c8-f0d7-49d5-af33-e11f2ddab3c7 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
The systemic half-life was 1.5 to 2.6 hours.
11 hours
- Numeric value
- 11
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:3db26227-208d-4fdd-8426-1d9be5cda9b4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
The mean apparent elimination half-life after dosing with the suppository was 11 hours (range 4 to 35 hours) and is considered to be limited by the absorption rate.
Projected row 316
- Medicine slug
- clindamycin
- Compared field
- tMax
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 158
- Source count
- 22
- Agreement rate
- 0.818182
- Recorded readings
3 hours
- Numeric value
- 3
- Unit
- hours
- Source records
- 18
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 18 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:dc8b8a09-3eed-1998-e053-2995a90a2f60 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:7a6967b3-5563-4bed-9eee-d400f800e799 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e4fc2d5-985a-3734-e053-2995a90aef5b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:12ee0720-9979-3162-e063-6394a90a8003 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e545c9d-dc39-584c-e053-2995a90afda4 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1a42c3b2-90b5-4a78-9f18-fa789742b033 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e549ceb-00e8-64b8-e053-2a95a90aef0f (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:406534a6-2234-4735-ba8f-7de4c87592e6 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8a4e2ba4-90e6-48e8-a943-0c5d3f169780 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:184acaee-6129-479e-850f-d89575b8b391 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:44fa506b-90ac-42de-831b-5f3f1a500fc0 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:05a75685-0af5-407c-ac57-e380c882b49d (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:38416189-844b-939f-e063-6394a90aa271 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:78832ac6-04c5-45e0-ae4d-f56d7920dda9 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:896a046f-95d0-100e-e053-2a95a90aa59c (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e500a08-0339-eb6b-e053-2a95a90a130c (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:9e5365a0-dd47-264a-e053-2a95a90a7fb8 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
After intramuscular injection of clindamycin phosphate, peak concentrations of active clindamycin are reached within 3 hours in adults and 1 hour in pediatric patients.
10 hours
- Numeric value
- 10
- Unit
- hours
- Source records
- 3
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 3 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b52bdaf7-3b54-4165-9ab0-9dfa08170e47 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
These peak concentrations were attained approximately 10 hours post-dosing (range 4–24 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:f9be442d-0782-4b93-828f-9ebbf67dbced (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
These peak concentrations were attained approximately 10 hours post-dosing (range 4–24 hours).
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:997a23c8-f0d7-49d5-af33-e11f2ddab3c7 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
These peak concentrations were attained approximately 10 hours post-dosing (range 4 to 24 hours).
6 hours
- Numeric value
- 6
- Unit
- hours
- Source records
- 1
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 1 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0423007f-28fa-4159-bf58-9174626d2347 (opens source in a new tab)
Clindamycin label
Version not recorded · Effective date not recorded
The median (range) t max occurred at 6 hours (4 to 96 hours).
Projected row 317
- Medicine slug
- clobazam
- Compared field
- bioavailability
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 22
- Source count
- 21
- Agreement rate
- 1
- Recorded readings
100%
- Numeric value
- 100
- Unit
- %
- Source records
- 21
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 21 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:574a3f91-d73e-46bc-b4a1-2388439521fb (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f94e10e-ee4e-44e1-9c84-16c5d8c9b594 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fce3252-95f8-4428-9922-5ba308e20177 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75fcff4a-1b35-4d92-8477-ff5ce7427f5f (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17c3b9db-9e25-4a17-ac45-bcd17ea0360c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6332e71c-3b37-422c-838c-8a2489ac6009 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf5bb37f-5386-47d3-8cec-d48253d359f6 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf31b8d1-0d19-4529-99b6-1f7366064a3c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2166ea46-28ff-f492-e063-6394a90a4a45 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de03bd69-2dca-459c-93b4-541fd3e9571c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:721dde68-db83-4dad-8649-8046cb455372 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b92ac57-25aa-4c00-b062-dee3944b271b (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0f (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6783eaa8-e236-4957-aaa9-b42bf8e709a7 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9b51794-3cfa-4a34-b5bb-d523b5798c17 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral suspension is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07e0ae51-cc71-427f-83cb-311b7fcc5993 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b5749a1-1c6d-4243-a833-4bfd84f9d5a9 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9e03a2a-3fea-4c98-ab71-415e6ebda3e0 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd1e63bf-496c-427c-83b7-6acabc00a5e5 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6da2c381-057b-456a-b57b-464f8b383371 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a526ad73-d3c1-40b7-8e71-426b01cdea27 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The relative bioavailability of clobazam tablets compared to an oral solution is approximately 100%.
Projected row 318
- Medicine slug
- clobazam
- Compared field
- proteinBinding
- Comparison state
- insufficient_context
- Reason codes
- STRUCTURED_CONTEXT_MISSING
- Documents examined
- 22
- Source count
- 22
- Agreement rate
- 0.590909
- Recorded readings
80 to 90%
- Numeric value
- 80
- Unit
- %
- Source records
- 13
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 13 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:574a3f91-d73e-46bc-b4a1-2388439521fb (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f94e10e-ee4e-44e1-9c84-16c5d8c9b594 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e3d8fcb-aa7d-4822-88fc-4f06264c3242 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80-90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75fcff4a-1b35-4d92-8477-ff5ce7427f5f (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17c3b9db-9e25-4a17-ac45-bcd17ea0360c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80-90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf5bb37f-5386-47d3-8cec-d48253d359f6 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80-90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf31b8d1-0d19-4529-99b6-1f7366064a3c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de03bd69-2dca-459c-93b4-541fd3e9571c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80-90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:721dde68-db83-4dad-8649-8046cb455372 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9b51794-3cfa-4a34-b5bb-d523b5798c17 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b5749a1-1c6d-4243-a833-4bfd84f9d5a9 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9e03a2a-3fea-4c98-ab71-415e6ebda3e0 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd1e63bf-496c-427c-83b7-6acabc00a5e5 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80 to 90% and 70%, respectively.
80%
- Numeric value
- 80
- Unit
- %
- Source records
- 9
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 9 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fce3252-95f8-4428-9922-5ba308e20177 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6332e71c-3b37-422c-838c-8a2489ac6009 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2166ea46-28ff-f492-e063-6394a90a4a45 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b92ac57-25aa-4c00-b062-dee3944b271b (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0f (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6783eaa8-e236-4957-aaa9-b42bf8e709a7 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07e0ae51-cc71-427f-83cb-311b7fcc5993 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6da2c381-057b-456a-b57b-464f8b383371 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a526ad73-d3c1-40b7-8e71-426b01cdea27 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The in vitro plasma protein binding of clobazam and N-desmethylclobazam is approximately 80% to 90% and 70%, respectively.
Projected row 319
- Medicine slug
- clobazam
- Compared field
- volumeOfDistribution
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 22
- Source count
- 22
- Agreement rate
- 1
- Recorded readings
100 L
- Numeric value
- 100
- Unit
- L
- Source records
- 22
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 22 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:574a3f91-d73e-46bc-b4a1-2388439521fb (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6f94e10e-ee4e-44e1-9c84-16c5d8c9b594 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:8fce3252-95f8-4428-9922-5ba308e20177 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady-state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:5e3d8fcb-aa7d-4822-88fc-4f06264c3242 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:75fcff4a-1b35-4d92-8477-ff5ce7427f5f (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:17c3b9db-9e25-4a17-ac45-bcd17ea0360c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6332e71c-3b37-422c-838c-8a2489ac6009 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady-state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf5bb37f-5386-47d3-8cec-d48253d359f6 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:cf31b8d1-0d19-4529-99b6-1f7366064a3c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:2166ea46-28ff-f492-e063-6394a90a4a45 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:de03bd69-2dca-459c-93b4-541fd3e9571c (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:721dde68-db83-4dad-8649-8046cb455372 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:4b92ac57-25aa-4c00-b062-dee3944b271b (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a77ffbdd-4e3e-4ec4-b0fa-b51ee610df0f (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6783eaa8-e236-4957-aaa9-b42bf8e709a7 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady-state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:c9b51794-3cfa-4a34-b5bb-d523b5798c17 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:07e0ae51-cc71-427f-83cb-311b7fcc5993 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:1b5749a1-1c6d-4243-a833-4bfd84f9d5a9 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:d9e03a2a-3fea-4c98-ab71-415e6ebda3e0 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fd1e63bf-496c-427c-83b7-6acabc00a5e5 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:6da2c381-057b-456a-b57b-464f8b383371 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady state was approximately 100 L.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:a526ad73-d3c1-40b7-8e71-426b01cdea27 (opens source in a new tab)
Clobazam label
Version not recorded · Effective date not recorded
The apparent volume of distribution at steady-state was approximately 100 L.
Projected row 320
- Medicine slug
- clofarabine
- Compared field
- halfLife
- Comparison state
- agree
- Reason codes
- COMPATIBLE_VALUES_OVERLAP
- Documents examined
- 7
- Source count
- 7
- Agreement rate
- 1
- Recorded readings
5.2 hours
- Numeric value
- 5.2
- Unit
- hours
- Source records
- 7
Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.
Show all 7 source records
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:54436453-882e-406b-87a3-049d150101c6 (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:b7d3a96e-0280-4f14-b921-795996f75950 (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0a273a2d-a1ff-412a-925e-696648730dae (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:fe6ff0f9-7610-4a69-9b75-da7ec4bb7744 (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:18adf4af-63ed-41e6-ab59-87085ce3e5fb (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:e956b1e0-2829-4872-8c09-99462d60e922 (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
- FDA_LABELRetrieved 2026-08-30FDA_LABEL:0da6764d-5fac-7e0f-ea3e-a5aee55a8b2d (opens source in a new tab)
Clofarabine label
Version not recorded · Effective date not recorded
The terminal half-life was 5.2 hours.
Access
Query or download the projection
GET /api/datasets/source-consensus?limit=10&offset=310Allowed query parameters
- q
- Case-insensitive text search over the public fields named for this dataset.
- state
- Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
- field
- Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
- limit / offset
- Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.
Reuse and corrections
Keep the boundary attached
CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.
Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.